UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Perioperative Management of Dabigatran: A Prospective Cohort Study

Circulation (New York, N.Y.), 2015-07, Vol.132 (3), p.167-173

2015

Volltextzugriff (PDF)

Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding

Circulation (New York, N.Y.), 2013-04, Vol.127 (13), p.1404-1412

2013

Volltextzugriff (PDF)

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Circulation (New York, N.Y.), 2014-02, Vol.129 (7), p.764-772

2014

Volltextzugriff (PDF)

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis

Circulation (New York, N.Y.), 2014-03, Vol.129 (9), p.961-970

2014

Volltextzugriff (PDF)

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial

Circulation (New York, N.Y.), 2012-07, Vol.126 (3), p.343-348

2012

Volltextzugriff (PDF)

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Circulation (New York, N.Y.), 2011-05, Vol.123 (21), p.2363-2372

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

Circulation (New York, N.Y.), 2011-06, Vol.123 (22), p.2562-2570

2011

Volltextzugriff (PDF)

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

Circulation (New York, N.Y.), 2013-11, Vol.128 (21), p.2325-2332

2013

Volltextzugriff (PDF)

Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

Circulation (New York, N.Y.), 2013-08, Vol.128 (7), p.721-728

2013

Volltextzugriff (PDF)

Lomitapide and Mipomersen: Two First-in-Class Drugs for Reducing Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia

Circulation (New York, N.Y.), 2014-03, Vol.129 (9), p.1022-1032

2014

Volltextzugriff (PDF)

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

Circulation (New York, N.Y.), 2012-02, Vol.125 (5), p.669-676

2012

Volltextzugriff (PDF)

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials

Circulation (New York, N.Y.), 2015-04, Vol.131 (17), p.1486-1494

2015

Volltextzugriff (PDF)

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation (New York, N.Y.), 2011-01, Vol.123 (2), p.131-136

2011

Volltextzugriff (PDF)

Dabigatran Etexilate: A New Oral Thrombin Inhibitor

Circulation (New York, N.Y.), 2011-04, Vol.123 (13), p.1436-1450

2011

Volltextzugriff (PDF)

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects

Circulation (New York, N.Y.), 2011-10, Vol.124 (14), p.1573-1579

2011

Volltextzugriff (PDF)

Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

Circulation (New York, N.Y.), 2011-10, Vol.124 (16), p.1727-1736

2011

Volltextzugriff (PDF)

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Circulation (New York, N.Y.), 2013-02, Vol.127 (5), p.634-640

2013

Volltextzugriff (PDF)

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Circulation (New York, N.Y.), 2007-03, Vol.115 (11), p.1371-1375

2007

Volltextzugriff (PDF)

Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study

Circulation (New York, N.Y.), 2013-11, Vol.128 (20), p.2192-2201

2013

Volltextzugriff (PDF)

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Circulation (New York, N.Y.), 2006-02, Vol.113 (5), p.671-678

2006

Volltextzugriff (PDF)

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Circulation (New York, N.Y.), 2007-09, Vol.116 (13), p.1482-1487

2007

Volltextzugriff (PDF)

Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies

Circulation (New York, N.Y.), 2011-03, Vol.123 (10), p.1098-1107

2011

Volltextzugriff (PDF)

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Circulation (New York, N.Y.), 2005-12, Vol.112 (24), p.3738-3744

2005

Volltextzugriff (PDF)

Beyond unfractionated heparin and warfarin : Current and future advances

Circulation (New York, N.Y.), 2007-07, Vol.116 (5), p.552-560

2007

Volltextzugriff (PDF)

Dabigatran and Warfarin in Vitamin K Antagonist-Naive and -Experienced Cohorts With Atrial Fibrillation

Circulation (New York, N.Y.), 2010-11, Vol.122 (22), p.2246-2253

2010

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCirculation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)
Japanisch
(9)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Perioperative Management of Dabigatran: A Prospective Cohort Study

Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis

Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin

Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

Lomitapide and Mipomersen: Two First-in-Class Drugs for Reducing Low-Density Lipoprotein Cholesterol in Patients With Homozygous Familial Hypercholesterolemia

Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Dabigatran Etexilate: A New Oral Thrombin Inhibitor

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects

Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk

Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure

Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies

Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients

Beyond unfractionated heparin and warfarin : Current and future advances

Dabigatran and Warfarin in Vitamin K Antagonist-Naive and -Experienced Cohorts With Atrial Fibrillation

Aktive Filter

Suchergebnisse filtern